0.239
0.00 (-0.37%)
| Previous Close | 0.240 |
| Open | 0.220 |
| Volume | 410,924 |
| Avg. Volume (3M) | 933,321 |
| Market Cap | 33,196,644 |
| Price / Earnings (Forward) | 7.89 |
| Price / Sales | 0.060 |
| Price / Book | 0.110 |
| 52 Weeks Range |
| Profit Margin | -24.95% |
| Operating Margin (TTM) | -17.76% |
| Diluted EPS (TTM) | -0.960 |
| Quarterly Revenue Growth (YOY) | -34.60% |
| Total Debt/Equity (MRQ) | 153.47% |
| Current Ratio (MRQ) | 1.05 |
| Operating Cash Flow (TTM) | -6.42 M |
| Levered Free Cash Flow (TTM) | -2.88 M |
| Return on Assets (TTM) | -36.73% |
| Return on Equity (TTM) | -336.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | Flora Growth Corp. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | 0.50 |
|
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 12.70% |
| % Held by Institutions | 3.96% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |